Beam Therapeutics Inc

11. sept 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, likely influenced by a rise in CRISPR Therapeutics following a narrower-than-expected U.S. budget deficit.

10. sept 2026, 23:11 UTC

Beam Therapeutics Inc shares declined in after-market trading, marking the fourth consecutive session of losses and closing significantly below their 20-day moving average.

9. sept 2026, 23:06 UTC

Beam Therapeutics shares are trading higher in after-market hours following a presentation at Citigroup's Biopharma Summit, highlighting advancements in its pipeline.

8. sept 2026, 20:03 UTC

Beam Therapeutics shares are lower despite presenting promising clinical data for BEAM-302 therapy at the European Respiratory Society Congress, amid regulatory concerns.

4. sept 2026, 23:00 UTC

Beam Therapeutics Inc shares are trading higher in after-market hours, continuing a steady increase since Friday's close amid mixed economic signals.

1. sept 2026, 19:36 UTC

Beam Therapeutics appointed Eric Foster as chief commercial officer. Shares are trading lower despite the leadership change amid preparations for a 2027 product launch.

31. aug 2026, 19:16 UTC

Beam Therapeutics Inc. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average.

28. aug 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, advancing since Friday's close and positioned above its 20-day moving average.

27. aug 2026, 23:02 UTC

Beam Therapeutics Inc. shares are roughly flat in after-market hours with no specific news identified. The stock remains above its 20-day moving average.

26. aug 2026, 23:51 UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

25. aug 2026, 20:07 UTC

HC Wainwright reiterated its Buy rating on Beam Therapeutics, maintaining a $80 price target. Shares are gaining amid positive sentiment and elevated call activity.

24. aug 2026, 20:06 UTC

Beam Therapeutics Inc shares are lower today amid rising oil prices and geopolitical tensions, with no specific news identified to explain the decline.

21. aug 2026, 23:31 UTC

Beam Therapeutics Inc. shares gained in after-market trading, reflecting broader market recovery as traders engaged in bargain hunting following a recent downturn.

20. aug 2026, 22:16 UTC

Beam Therapeutics Inc. shares advanced in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

19. aug 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

18. aug 2026, 19:16 UTC

Shares of Beam Therapeutics are lower today, having declined since Monday amid broader small-cap losses and rising U.S. Treasury yields.

14. aug 2026, 19:36 UTC

Beam Therapeutics is trading higher during Friday's session, recovering from an earlier dip. No specific news has been identified to explain the price action.

13. aug 2026, 23:01 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, reflecting notable upward momentum since Thursday's close, despite no specific news identified.

12. aug 2026, 20:06 UTC

Beam Therapeutics Inc. shares are lower today, continuing a trend of declines since Tuesday's close amid broader market uncertainties and lower U.S. Treasury yields.

11. aug 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, following a session peak. No specific news was identified to explain the price movement.

5. aug 2026, 19:52 UTC

Beam Therapeutics Inc is trading lower as broader market sentiment weakens. The decline follows disappointing ADP employment data, which missed expectations significantly.

4. aug 2026, 23:06 UTC

Beam Therapeutics Inc. shares are lower in after-market hours, following a session low shortly after the open, despite three consecutive higher daily closes.

3. aug 2026, 19:16 UTC

Beam Therapeutics is rising amid a broader market rally, with a market cap of $2.64 billion and $1.2 billion in liquidity to support operations.

31. juuli 2026, 19:16 UTC

Beam Therapeutics shares are lower, reflecting a decline in first-quarter results and broader sector weakness. The stock remains near the lower end of its one-month range.

30. juuli 2026, 23:06 UTC

Beam Therapeutics Inc shares are higher in after-hours trading, advancing since Thursday's close, despite remaining below the 20-day moving average.

29. juuli 2026, 22:51 UTC

Beam Therapeutics shares are lower in after-market hours following a volatile session, amid broader market uncertainty after the Federal Reserve's interest rate decision.

28. juuli 2026, 23:51 UTC

Beam Therapeutics Inc shares are lower in after-market trading, experiencing unusual volatility amid broader market declines and positioned below its 20-day moving average.

27. juuli 2026, 23:06 UTC

Beam Therapeutics Inc shares are higher in after-market hours, despite a broader decline in trading. No specific news was identified to explain the increase.

24. juuli 2026, 19:26 UTC

Beam Therapeutics is declining today, reflecting broader market trends, with the Russell 2000 Index down. The stock remains below its 20-day moving average.

23. juuli 2026, 09:51 UTC

Beam Therapeutics is higher in pre-market trading, driven by significant upcoming clinical milestones, including the global BEAM-302 trial and an FDA application for risto-cel.